Home > Insider Trading > Filing (0000899243-23-011187)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1832415	Better Therapeutics Inc.	BTTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1807550	J. Andrew Armanino	C/O Better Therapeutics, Inc. 548 Market Street, #49404 San Francisco CA 94104		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-10	303,030	$0.83	454,358	No	4	P	Indirect	By Armanino Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Armanino Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	13,334	Direct

Footnotes

On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 303,030 shares of Issuer common stock on April 10, 2023 for $0.825 per share.
The Reporting Person no longer has a reportable beneficial interest in 15,000 shares of Issuer common stock owned by his son and included in the Reporting Person's prior ownership report on Form 4.
These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust"), and indirectly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.